Insider · CIK 0001875786
Martin Auster
Files at VTYX (Ventyx Biosciences, Inc.). First filing Dec 6, 2022, latest Apr 3, 2024.
In brief
Martin Auster files SEC Form 4 as CFO at VTYX (Ventyx Biosciences, Inc.). Since Dec 6, 2022, Martin Auster has reported 0 open-market buys worth $0 and 2 open-market sells worth $2.8M, the latest filed on Apr 3, 2024.
A track record needs three past buys with six months of prices behind them; Martin Auster has 0, so none is measured yet.
The newest scored trade: sold $7,592 of VTYX on Apr 2, 2024, filed Apr 3, 2024, scored 37 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | Ventyx Biosciences, Inc. | $7,592 1,405 shares | -5% | - | |
| 52Moderate | VTYXsell Ventyx Biosciences, Inc. | $2.8M 97,647 shares | -67% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 2, 2024 | VTYX Ventyx Biosciences, Inc. | 1,405 0.00% of outstanding | $7,592 | Apr 2, 2024 | none |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 2, 2024 | VTYX Ventyx Biosciences, Inc. | SOpen-market sale Common Stock | -1,405 | $5.40 | $7,592 | 24,303 | Apr 3, 2024 |
| Mar 28, 2024 | VTYX Ventyx Biosciences, Inc. | MOption exercise Common Stock | +4,531 | $0.00 | $0 | 25,708 | Mar 29, 2024 |
| Mar 28, 2024 | VTYX Ventyx Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -4,531 | $0.00 | $0 | 13,594 | Mar 29, 2024 |
| Jan 2, 2024 | VTYX Ventyx Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Jan 3, 2024 |
| Dec 18, 2023 | VTYX Ventyx Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +181,250 | $0.00 | $0 | 181,250 | Dec 19, 2023 |
| Dec 2, 2022 | VTYX Ventyx Biosciences, Inc. | MOption exercise Common Stock | +50,000 | $3.45 | $173k | 145,296 | Dec 6, 2022 |
| Dec 2, 2022 | VTYX Ventyx Biosciences, Inc. | SOpen-market sale Common Stock | -97,647 | $29.01 | $2.8M | 47,649 | Dec 6, 2022 |
| Dec 2, 2022 | VTYX Ventyx Biosciences, Inc. | MOption exercise Stock Option (right to buy)derivative | -50,000 | $0.00 | $0 | 331,184 | Dec 6, 2022 |
Questions about Martin Auster
Answered from the filings on this page, as of the latest one.
Is Martin Auster buying or selling?
Not in the last 12 months. Martin Auster's latest open-market trade on SEC Form 4 was sold $7,592 of VTYX on Apr 2, 2024.
How did Martin Auster's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Martin Auster has 0.
Where does Martin Auster file Form 4?
Martin Auster has filed Form 4 at VTYX (Ventyx Biosciences, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.